Publications

Comparative Study
Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 75 citations
Electronic publication date
August 27, 2013

View on Pubmed.gov 23457534 | View on doi.org 10.1371/journal...

Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.

Search for publications in this journal PLoS One - 8(2):e56248

Abstract

BACKGROUND

Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of important issues.

METHODS

All adult smear-positive pulmonary TB patients diagnosed between 2008 and 2010 in Malawi's largest public, integrated TB/HIV clinic were included in the study to assess treatment outcomes by HIV and antiretroviral therapy status using logistic regression.

RESULTS

Of 2,361 new smear-positive pulmonary TB patients, 86% had successful treatment outcome (were cured or completed treatment), 5% died, 6% were lost to follow-up, 1% failed treatment, and 2% transferred-out. Overall HIV prevalence was 56%. After adjusting for gender, age and TB registration year, treatment success was higher among HIV-negative than HIV-positive patients (adjusted odds ratio 1.49; 95% CI: 1.14-1.94). Of 1,275 HIV-infected pulmonary TB patients, 492 (38%) received antiretroviral therapy during the study. Pulmonary TB patients on antiretroviral therapy were more likely to have successful treatment outcomes than those not on ART (adjusted odds ratio : 1.83; 95% CI: 1.29-2.60).

CONCLUSION

HIV co-infection was associated with poor TB treatment outcomes. Despite high HIV prevalence and the integrated TB/HIV setting, only a minority of patients started antiretroviral therapy. Intensified patient education and provider training on the benefits of antiretroviral therapy could increase antiretroviral therapy uptake and improve TB treatment success among these most infectious patients.

References

Trop Med Int Health. 2011 Nov;16(11):1397-403

HIV AIDS (Auckl). 2012;4:117-24

East Afr Med J. 2009 Oct;86(10):469-75

J Infect Dis. 2004 Nov 1;190(9):1670-6

Cited by 75 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.

Electronic publication date March 5, 2016

Search for publications in this journal PLoS One

Jamshid Gadoev [...] Masoud Dara et al.

BACKGROUND

TB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently...

Journal Article

Prevalence and Factors Associated with Tuberculosis Treatment Success among TB/HIV Co-Infection in North-East Malaysia.

Electronic publication date January 31, 2018

Search for publications in this journal Malays J Med Sci

Tengku Mardhiah Tengku Jalal [...] Nyi Nyi Naing et al.

BACKGROUND

One of the six strategies developed by WHO, in order to stop Tuberculosis (TB) is addressing TB/HIV high-risk groups. This...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances